Targeted nanomedicines for the treatment of Helicobacter pylori infection
Helicobacter pylori is a significant risk factor for gastric cancer, making its elimination crucial for prevention. This review explores the application of nanotechnology in enhancing treatment efficacy against H. pylori and addressing antibiotic resistance. Nanomaterials are utilized as drug carrie...
Saved in:
| Main Authors: | Shi Wang, Hao Ding, Longsong Li, Ruifang Zhao, Ningli Chai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Materials Today Bio |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2590006425003801 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of Helicobacter Pylori – an Overview of Current Strategies of Diagnostic and Treatment
by: Ruxandra BABIUC, et al.
Published: (2021-09-01) -
Challenges and Prospects for Eradication of <i>Helicobacter pylori</i>: Targeting Virulence Factors, Metabolism, and Vaccine Innovation
by: Adrian Bakiera, et al.
Published: (2025-06-01) -
Regional features of gastroduodenal disease, associated with Helicobacter pylori infection, in the North Ossetia
by: E. A. Kornienko, et al.
Published: (2014-09-01) -
Clinical and Pharmacological Aspects of Resistance to Eradication Therapy of Helicobacter Pylori Infection
by: S. Yu. Serebrova, et al.
Published: (2020-05-01) -
Status of Helicobacter pylori Eradication in Japan
by: Gwang Ha Kim
Published: (2017-03-01)